Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii
In a previous study, we reported that human milk oligosaccharides (HMOs) isolated from five donor milk samples possessed antimicrobial and antibiofilm activity against Streptococcus agalactiae, also known as Group B Streptococcus or GBS. Herein, we present a broader evaluation of the antimicrobial a...
Gespeichert in:
Veröffentlicht in: | ACS infectious diseases 2018-03, Vol.4 (3), p.315-324 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 324 |
---|---|
container_issue | 3 |
container_start_page | 315 |
container_title | ACS infectious diseases |
container_volume | 4 |
creator | Ackerman, Dorothy L Craft, Kelly M Doster, Ryan S Weitkamp, Jörn-Hendrik Aronoff, David M Gaddy, Jennifer A Townsend, Steven D |
description | In a previous study, we reported that human milk oligosaccharides (HMOs) isolated from five donor milk samples possessed antimicrobial and antibiofilm activity against Streptococcus agalactiae, also known as Group B Streptococcus or GBS. Herein, we present a broader evaluation of the antimicrobial and antibiofilm activity by screening HMOs from 14 new donors against three strains of GBS and two of the ESKAPE pathogens of particular interest to child health, Staphylococcus aureus and Acinetobacter baumannii. Growth and biofilm assays showed that HMOs from these new donors possessed antimicrobial and antibiofilm activity against all three strains of GBS, antibiofilm activity against methicillin-resistant S. aureus strain USA300, and antimicrobial activity against A. baumannii strain ATCC 19606. |
doi_str_mv | 10.1021/acsinfecdis.7b00183 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6019282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1972301165</sourcerecordid><originalsourceid>FETCH-LOGICAL-a511t-de4db4cf36b56fcefd5d4229ec9f1de31039ba7c83d5b0860f0dec498ea2be453</originalsourceid><addsrcrecordid>eNp9UctuEzEUHSEQrUq_AAl5yaJp_ZjnBimqCkUq6gJYW9f2ncTFYwfbUym_wtfikBCFDStb97yu7qmqt4xeM8rZDehk_Yja2HTdKUpZL15U51x0YtFz3r08-Z9Vlyk90cIRfVPXzevqjA9s6IvPefVr6bOdrI5BWXAEvCG7ibJhtG4iS53ts81bEkZyP0_gyRfrfpBHZ1chgdZriNZgIrAC61MmX3PETQ46aD3_mTooDoBXBYHNeuuO0BxxTlf7QG095qAKFSNRsMvx1r6pXo3gEl4e3ovq-8e7b7f3i4fHT59vlw8LaBjLC4O1UbUeRauadtQ4msbUnA-oh5EZFIyKQUGne2EaRfuWjtSgrocegSusG3FRfdj7bmY1odHocwQnN9FOELcygJX_It6u5So8y5aygfe8GLw_GMTwc8aU5WSTRufAY5iTZEPHBWWs3WWJPbUcPKWI4zGGUbkrVp4UKw_FFtW70w2Pmr81FsLNnlDU8inM0ZeD_dfyN8H2uGI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1972301165</pqid></control><display><type>article</type><title>Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Ackerman, Dorothy L ; Craft, Kelly M ; Doster, Ryan S ; Weitkamp, Jörn-Hendrik ; Aronoff, David M ; Gaddy, Jennifer A ; Townsend, Steven D</creator><creatorcontrib>Ackerman, Dorothy L ; Craft, Kelly M ; Doster, Ryan S ; Weitkamp, Jörn-Hendrik ; Aronoff, David M ; Gaddy, Jennifer A ; Townsend, Steven D</creatorcontrib><description>In a previous study, we reported that human milk oligosaccharides (HMOs) isolated from five donor milk samples possessed antimicrobial and antibiofilm activity against Streptococcus agalactiae, also known as Group B Streptococcus or GBS. Herein, we present a broader evaluation of the antimicrobial and antibiofilm activity by screening HMOs from 14 new donors against three strains of GBS and two of the ESKAPE pathogens of particular interest to child health, Staphylococcus aureus and Acinetobacter baumannii. Growth and biofilm assays showed that HMOs from these new donors possessed antimicrobial and antibiofilm activity against all three strains of GBS, antibiofilm activity against methicillin-resistant S. aureus strain USA300, and antimicrobial activity against A. baumannii strain ATCC 19606.</description><identifier>ISSN: 2373-8227</identifier><identifier>EISSN: 2373-8227</identifier><identifier>DOI: 10.1021/acsinfecdis.7b00183</identifier><identifier>PMID: 29198102</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject><![CDATA[Acinetobacter baumannii - drug effects ; Acinetobacter baumannii - growth & development ; Anti-Bacterial Agents - isolation & purification ; Anti-Bacterial Agents - pharmacology ; Biofilms - drug effects ; Biofilms - growth & development ; Biological Products - isolation & purification ; Biological Products - pharmacology ; Female ; Humans ; Microbial Sensitivity Tests ; Milk, Human - chemistry ; Oligosaccharides - isolation & purification ; Oligosaccharides - pharmacology ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - growth & development ; Streptococcus agalactiae - drug effects ; Streptococcus agalactiae - growth & development]]></subject><ispartof>ACS infectious diseases, 2018-03, Vol.4 (3), p.315-324</ispartof><rights>Copyright © 2017 American Chemical Society</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a511t-de4db4cf36b56fcefd5d4229ec9f1de31039ba7c83d5b0860f0dec498ea2be453</citedby><cites>FETCH-LOGICAL-a511t-de4db4cf36b56fcefd5d4229ec9f1de31039ba7c83d5b0860f0dec498ea2be453</cites><orcidid>0000-0003-4587-6121 ; 0000-0001-9753-2801 ; 0000-0001-5362-7235</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.7b00183$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acsinfecdis.7b00183$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,315,782,786,887,2767,27083,27931,27932,56745,56795</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29198102$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ackerman, Dorothy L</creatorcontrib><creatorcontrib>Craft, Kelly M</creatorcontrib><creatorcontrib>Doster, Ryan S</creatorcontrib><creatorcontrib>Weitkamp, Jörn-Hendrik</creatorcontrib><creatorcontrib>Aronoff, David M</creatorcontrib><creatorcontrib>Gaddy, Jennifer A</creatorcontrib><creatorcontrib>Townsend, Steven D</creatorcontrib><title>Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii</title><title>ACS infectious diseases</title><addtitle>ACS Infect. Dis</addtitle><description>In a previous study, we reported that human milk oligosaccharides (HMOs) isolated from five donor milk samples possessed antimicrobial and antibiofilm activity against Streptococcus agalactiae, also known as Group B Streptococcus or GBS. Herein, we present a broader evaluation of the antimicrobial and antibiofilm activity by screening HMOs from 14 new donors against three strains of GBS and two of the ESKAPE pathogens of particular interest to child health, Staphylococcus aureus and Acinetobacter baumannii. Growth and biofilm assays showed that HMOs from these new donors possessed antimicrobial and antibiofilm activity against all three strains of GBS, antibiofilm activity against methicillin-resistant S. aureus strain USA300, and antimicrobial activity against A. baumannii strain ATCC 19606.</description><subject>Acinetobacter baumannii - drug effects</subject><subject>Acinetobacter baumannii - growth & development</subject><subject>Anti-Bacterial Agents - isolation & purification</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Biofilms - drug effects</subject><subject>Biofilms - growth & development</subject><subject>Biological Products - isolation & purification</subject><subject>Biological Products - pharmacology</subject><subject>Female</subject><subject>Humans</subject><subject>Microbial Sensitivity Tests</subject><subject>Milk, Human - chemistry</subject><subject>Oligosaccharides - isolation & purification</subject><subject>Oligosaccharides - pharmacology</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - growth & development</subject><subject>Streptococcus agalactiae - drug effects</subject><subject>Streptococcus agalactiae - growth & development</subject><issn>2373-8227</issn><issn>2373-8227</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UctuEzEUHSEQrUq_AAl5yaJp_ZjnBimqCkUq6gJYW9f2ncTFYwfbUym_wtfikBCFDStb97yu7qmqt4xeM8rZDehk_Yja2HTdKUpZL15U51x0YtFz3r08-Z9Vlyk90cIRfVPXzevqjA9s6IvPefVr6bOdrI5BWXAEvCG7ibJhtG4iS53ts81bEkZyP0_gyRfrfpBHZ1chgdZriNZgIrAC61MmX3PETQ46aD3_mTooDoBXBYHNeuuO0BxxTlf7QG095qAKFSNRsMvx1r6pXo3gEl4e3ovq-8e7b7f3i4fHT59vlw8LaBjLC4O1UbUeRauadtQ4msbUnA-oh5EZFIyKQUGne2EaRfuWjtSgrocegSusG3FRfdj7bmY1odHocwQnN9FOELcygJX_It6u5So8y5aygfe8GLw_GMTwc8aU5WSTRufAY5iTZEPHBWWs3WWJPbUcPKWI4zGGUbkrVp4UKw_FFtW70w2Pmr81FsLNnlDU8inM0ZeD_dfyN8H2uGI</recordid><startdate>20180309</startdate><enddate>20180309</enddate><creator>Ackerman, Dorothy L</creator><creator>Craft, Kelly M</creator><creator>Doster, Ryan S</creator><creator>Weitkamp, Jörn-Hendrik</creator><creator>Aronoff, David M</creator><creator>Gaddy, Jennifer A</creator><creator>Townsend, Steven D</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4587-6121</orcidid><orcidid>https://orcid.org/0000-0001-9753-2801</orcidid><orcidid>https://orcid.org/0000-0001-5362-7235</orcidid></search><sort><creationdate>20180309</creationdate><title>Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii</title><author>Ackerman, Dorothy L ; Craft, Kelly M ; Doster, Ryan S ; Weitkamp, Jörn-Hendrik ; Aronoff, David M ; Gaddy, Jennifer A ; Townsend, Steven D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a511t-de4db4cf36b56fcefd5d4229ec9f1de31039ba7c83d5b0860f0dec498ea2be453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acinetobacter baumannii - drug effects</topic><topic>Acinetobacter baumannii - growth & development</topic><topic>Anti-Bacterial Agents - isolation & purification</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Biofilms - drug effects</topic><topic>Biofilms - growth & development</topic><topic>Biological Products - isolation & purification</topic><topic>Biological Products - pharmacology</topic><topic>Female</topic><topic>Humans</topic><topic>Microbial Sensitivity Tests</topic><topic>Milk, Human - chemistry</topic><topic>Oligosaccharides - isolation & purification</topic><topic>Oligosaccharides - pharmacology</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - growth & development</topic><topic>Streptococcus agalactiae - drug effects</topic><topic>Streptococcus agalactiae - growth & development</topic><toplevel>online_resources</toplevel><creatorcontrib>Ackerman, Dorothy L</creatorcontrib><creatorcontrib>Craft, Kelly M</creatorcontrib><creatorcontrib>Doster, Ryan S</creatorcontrib><creatorcontrib>Weitkamp, Jörn-Hendrik</creatorcontrib><creatorcontrib>Aronoff, David M</creatorcontrib><creatorcontrib>Gaddy, Jennifer A</creatorcontrib><creatorcontrib>Townsend, Steven D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ackerman, Dorothy L</au><au>Craft, Kelly M</au><au>Doster, Ryan S</au><au>Weitkamp, Jörn-Hendrik</au><au>Aronoff, David M</au><au>Gaddy, Jennifer A</au><au>Townsend, Steven D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii</atitle><jtitle>ACS infectious diseases</jtitle><addtitle>ACS Infect. Dis</addtitle><date>2018-03-09</date><risdate>2018</risdate><volume>4</volume><issue>3</issue><spage>315</spage><epage>324</epage><pages>315-324</pages><issn>2373-8227</issn><eissn>2373-8227</eissn><abstract>In a previous study, we reported that human milk oligosaccharides (HMOs) isolated from five donor milk samples possessed antimicrobial and antibiofilm activity against Streptococcus agalactiae, also known as Group B Streptococcus or GBS. Herein, we present a broader evaluation of the antimicrobial and antibiofilm activity by screening HMOs from 14 new donors against three strains of GBS and two of the ESKAPE pathogens of particular interest to child health, Staphylococcus aureus and Acinetobacter baumannii. Growth and biofilm assays showed that HMOs from these new donors possessed antimicrobial and antibiofilm activity against all three strains of GBS, antibiofilm activity against methicillin-resistant S. aureus strain USA300, and antimicrobial activity against A. baumannii strain ATCC 19606.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>29198102</pmid><doi>10.1021/acsinfecdis.7b00183</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-4587-6121</orcidid><orcidid>https://orcid.org/0000-0001-9753-2801</orcidid><orcidid>https://orcid.org/0000-0001-5362-7235</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2373-8227 |
ispartof | ACS infectious diseases, 2018-03, Vol.4 (3), p.315-324 |
issn | 2373-8227 2373-8227 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6019282 |
source | MEDLINE; American Chemical Society Journals |
subjects | Acinetobacter baumannii - drug effects Acinetobacter baumannii - growth & development Anti-Bacterial Agents - isolation & purification Anti-Bacterial Agents - pharmacology Biofilms - drug effects Biofilms - growth & development Biological Products - isolation & purification Biological Products - pharmacology Female Humans Microbial Sensitivity Tests Milk, Human - chemistry Oligosaccharides - isolation & purification Oligosaccharides - pharmacology Staphylococcus aureus - drug effects Staphylococcus aureus - growth & development Streptococcus agalactiae - drug effects Streptococcus agalactiae - growth & development |
title | Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T15%3A40%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20and%20Antibiofilm%20Activity%20of%20Human%20Milk%20Oligosaccharides%20against%20Streptococcus%20agalactiae,%20Staphylococcus%20aureus,%20and%20Acinetobacter%20baumannii&rft.jtitle=ACS%20infectious%20diseases&rft.au=Ackerman,%20Dorothy%20L&rft.date=2018-03-09&rft.volume=4&rft.issue=3&rft.spage=315&rft.epage=324&rft.pages=315-324&rft.issn=2373-8227&rft.eissn=2373-8227&rft_id=info:doi/10.1021/acsinfecdis.7b00183&rft_dat=%3Cproquest_pubme%3E1972301165%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1972301165&rft_id=info:pmid/29198102&rfr_iscdi=true |